Abstract
OBJECTIVE To explore public attitudes to the proposed COVID-19 contact tracing app in the United Kingdom.
DESIGN Qualitative study consisting of five focus groups carried out between 1st-4th May, 2020 (39–42 days after the official start of the UK lockdown).
SETTING Online video-conferencing
PARTICIPANTS 22 participants, all UK residents aged 18 years and older, representing a range of different genders, ages, ethnicities and locations.
RESULTS Participants were split roughly equally in number across three groups: will use the app; will not be using the app; and undecided as to whether they will use the app. Analysis revealed five main themes: (1) Lack of information and misconceptions surrounding COVID-19 contact tracing apps; (2) concerns over privacy; (3) concerns over stigma; (4) concerns over uptake; and (5) contact tracing as the ‘greater good’. These themes were found across the sample and the three groups. However, concerns over privacy, uptake and stigma were particularly significant amongst those state they will not be using the app and the view that the app is for the “greater good” was particularly significant amongst those who stated they will be using the app. One of the most common misconceptions about the app was that it could allow users to specifically identify and map COVID-19 cases amongst their contacts and in their vicinity.
CONCLUSIONS We offer four recommendations: (1) To offset the fact that many people may not be accessing, or might be avoiding, news coverage on COVID-19, authorities must communicate to the public via a range of methods including but not limited to: social media ads, postal information, text messaging and other emergency alert systems. (2) Communications should emphasise that the app cannot enable the user to identify which of their contacts has reported COVID-19 symptoms or tested positive. (3) Communication should emphasise collective responsibility (‘the greater good’) to promote social norms around use of the app (4) Communication should provide a slogan that maximises clarity of message, for example: ‘Download the app, protect the NHS, save lives’.
Competing Interest Statement
Armitage is supported by NIHR Manchester Biomedical Research Centre and NIHR Greater Manchester Patient Safety Translational Research Centre. Tampe is an independent consultant and currently consults for the World Health Organization. The authors have no other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
This research was supported by the University of Manchester’s of Health Psychology Section research monies (£2000). The funders played no role in the conduct of the study.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
s.n.williams{at}swansea.ac.uk, chris.armitage{at}manchester.ac.uk, tova.tampe{at}gmail.com, kimberly.dienes{at}manchester.ac.uk
Data Availability
Ethical restrictions related to participant confidentiality prohibit the authors from making the data set publicly available. During the consent process, participants were explicitly guaranteed that the data would only be seen my members of the study team. For any discussions about the data set please contact the corresponding author, Simon Williams (s.n.williams@swansea.ac.uk).
